Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-22
2006-08-22
Tsang, Cecilia J. (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07094545
ABSTRACT:
The present invention relates to a novel pharmaceutical composition as a solid dosage form comprising desmopressin as a therapeutically active ingredient, and to a method for manufacturing thereof. The invention relates to a pharmaceutical composition as a solid dosage form comprising desmopressin, or a pharmaceutically acceptable salt thereof, as a therapeutically active ingredient together with a pharmaceutically acceptable excipient, diluent or carrier, or mixture thereof, wherein at least one of said excipient, diluent and carrier is a substance selected from a monosaccharide, disaccharide, oligosaccharide and a polysaccharide, wherein the said substance has an average particle size in the range of from 60 to 1,000 μm. A method according to the present invention provides an improved production of solid dosage forms of desmopressin.
REFERENCES:
patent: 4675188 (1987-06-01), Chu
patent: 4820627 (1989-04-01), McGeehan
patent: 5047398 (1991-09-01), Hagstam et al.
patent: 2002/0122817 (2002-09-01), Gabel et al.
patent: 2003/0091623 (2003-05-01), Cumming et al.
patent: 2003/0091637 (2003-05-01), Peterelt et al.
patent: 2003/0175214 (2003-09-01), Staniforth et al.
patent: 2003/0185764 (2003-10-01), Staniforth et al.
patent: 0 752 877 (2000-07-01), None
patent: 0 710 122 (2001-12-01), None
patent: 1 255 557 (2002-11-01), None
patent: WO 95/18602 (1995-07-01), None
patent: WO 97/15297 (1997-05-01), None
patent: WO 97/15297 (1997-05-01), None
patent: WO 97/23485 (1997-07-01), None
patent: WO 97/48379 (1997-12-01), None
patent: WO 98/10753 (1998-03-01), None
patent: WO 98/10753 (1998-03-01), None
patent: WO 00/9423 (2000-10-01), None
patent: WO 00/59423 (2000-10-01), None
patent: WO 01/78694 (2001-10-01), None
patent: WO 01/78695 (2001-10-01), None
patent: WO 01/78696 (2001-10-01), None
patent: WO 01/82906 (2001-11-01), None
patent: WO 02/00197 (2002-01-01), None
patent: WO 03/094886 (2003-11-01), None
“Current Issues and Troubleshooting Fluid Bed Granulation”, May 1998, Pharmaceutical Technology Europe, http://www.niroinc.com/html/pharma/phpdfs
iroreprint2.pdf.
“Pharmaceutical Dosage Forms: Tablets”; vol. 1, pp. 297-298, H.A. Lieberman et al., New York & Basel, 1989.
“Pharmaceutical Dosage Forms: Parenteral Medications”, vol. 3, pp. 27-29, H.A. Lieberman et al., New York & Basel, 1990.
“Pharmaceutics—The Science of Dosage Form Design”, pp. 625-627, M.E. Aulton et al., Edinburgh, London, Melbourne & New York, 1988.
“Handbook of Pharmacetical Excipients”, Ed. A.H. Kibble, 3rdEd., American Pharmaceutical Assocation, USAS and Pharmaceutical Press UK 2000.
N.A. Armstrong; “Tabletting”, Pharmaceutics—The Science of Dosage Form Design, pp. 647-668, 1988.
Robert O. Williams III et al., “Compaction Properties of Microscrystalline Cellulose and Sodium Sulfathlazole in Combination with Talc or Magnesium Stearate”, Journal of Pharmaceutical Sciences vol. 78, No. 12, Dec. 1989, pp. 1025-1034.
DMV International Product group overview for Pharmatose milled and sleved lactose.
DMV International Product group overview for Pharmatose DC lactose.
Hwang et al., “A Systematic Formulation Optimazation Process for a Generic Pharmaceutical Tablet,”Pharmaceutical Technology, pp. 48-64, May 1998.
Fast Flo Lactose — technical sheet, Jun. 2001.
Handbook of Pharmaceutical Excipients, 3rdEdition, Edited by Arthur Kibbe, The Pharmaceutical Press, 2000, pp. 276-285.
Lomryd Håkan
Nicklasson Helena
Olsson Lars-Erik
Audet Maury
Ferring BV
Foley & Lardner LLP
Tsang Cecilia J.
LandOfFree
Pharmaceutical composition as solid dosage form and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition as solid dosage form and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition as solid dosage form and method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3668428